ReviewInternational journal of food science2026
Fermented Milk as an Alternative Therapy for Obesity.
Review in International journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fermented Milk as an Alternative Therapy for Obesity.International journal of food science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is a global health concern closely associated with metabolic disorders, including fatty liver disease. Conventional treatment approaches rely on lifestyle modifications and pharmacological interventions, but functional foods, particularly fermented milk, have gained attention as promising alternatives. Fermented milk containing probiotics has emerged as a potential functional food for managing obesity and its complications, including nonalcoholic fatty liver disease (NAFLD). This review summarises current evidence on the role of probiotic-fermented milk in modulating lipid metabolism and related molecular pathways, with a focus on Sterol Regulatory Element-Binding Protein-1c (SREBP-1c). Probiotic fermentation can improve the composition of the gut microbiota, increase short-chain fatty acid production and regulate bile acid metabolism, thereby decreasing hepatic lipogenesis. Probiotic strains, such as
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.